sees qtr-three sales $num-one billion to $1.num-two billion.
sees fy adjusted earnings per share $num-one to $num - two.
sees qtr-one sales $num-one.num-txtillion to $1.0 billion.
qtr-four adjusted earnings per share $num-two.
qtr-two gaap earnings per share $num-one.
sees fy year-six surgical structural heart sales of $num-one million to $2.0 million.
sees qtr-three sales $num-one billion to $num - two billion.
sees fy sales $num-one billion to $num - two billion.
qtrly global sales of $num-one million decreased num-two% on an underlying basis over prior year.
qtr-four sales fell num-two percent to $num-one million.
qtr-four adjusted earnings per share $num-three.
qtrly global tavr sales of $num-one billion, up num-two% on an underlying basis.
sees fy year-six average diluted shares outstanding to be between num-one million and num-two million.
qtr-four sales rose num-two percent to $num-one billion.
qtr-four sales $num-one million versus refinitiv ibes estimate of $452.7 million.
qtrly global sales of $num-one million decreased num-two% on an underlying basis versus prior year.
